ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Illumina Inc

Illumina Inc (I1LM34Q)

156.81
0.00
( 0.00% )
Updated: 04:59:47

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
156.81
Bid
0.00
Ask
0.00
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Previous Close
156.81
Open
-
Last Trade
Last Trade Time
-
Average Volume (3m)
-
Financial Volume
-
VWAP
-

I1LM34Q Latest News

No news to show yet.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000DR
40000000DR
120000000DR
260000000DR
520000000DR
1560000000DR
2600000000DR

I1LM34Q - Frequently Asked Questions (FAQ)

What is the current Illumina share price?
The current share price of Illumina is R$ 156.81
What is the 1 year trading range for Illumina share price?
Illumina has traded in the range of R$ 0.00 to R$ 0.00 during the past year

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AZEV11Azevedo Travassos Sa
R$ 0.34
(17.24%)
2.6k
IFCM3Infracommerce Caxaas S.A.
R$ 0.08
(14.29%)
1.1M
CTKA3Karsten Sa ex Cia Textil Karsten
R$ 27.99
(14.24%)
100
PLAS3Plascar Participacoes Industriais Sa
R$ 6.99
(12.74%)
100
NTCO3Natura and Co Holding SA
R$ 13.13
(4.04%)
654.9k
BGIP4Bco Estado Sergipe Sa Banese
R$ 25.07
(-11.38%)
1.6k
BALM4Baumer Sa
R$ 10.55
(-6.64%)
400
INEP3Inepar Sa Ind Construcoes
R$ 1.35
(-5.59%)
1.1k
INEP4Inepar Sa Ind Construcoes
R$ 1.33
(-5.00%)
3.2k
NEXP3Nexpe Participacoes Sa
R$ 3.81
(-3.30%)
1.6k
AMOB3Automob Participacoes Sa
R$ 0.32
(3.23%)
12.3M
PETR4Petroleo Brasileiro S.A. Petrobras
R$ 37.52
(-0.451048%)
2.93M
VALE3Vale SA
R$ 53.81
(-0.66%)
2.05M
MGLU3Magaz Luiza
R$ 7.25
(-2.82%)
1.89M
ABEV3Ambev SA
R$ 11.07
(-0.27%)
1.81M

Discussion

View Full Feed
Dcab Dcab 5 minutes ago
This is week 12 since the validation test announcement. JMHO.
LUDG
Hoskuld Hoskuld 6 minutes ago
One concern I have with attacking our closest allies concerns my investment here in Anavex: will the EMA be generous with an American company's MAA or will it be more inclined to throw up roadblocks? Will our C-level European leadership be an asset at this time? Is the MAA filed out of the Swiss o
AVXL
dennisdave dennisdave 6 minutes ago
ATLnsider I trust that https://find-and-update.company-information.service.gov.uk/company/08717711/filing-history is better informed than you are
Never in my life I hav eever encountered such prejudiced againt reality as the NWBO zealots groupies. Its posts such as your that spread the lies
NWBO
tedpeele tedpeele 6 minutes ago
does seem questionable -- certainly a very impressive result -- but one person only --- abberations do occur
BCTX
Monroe1 Monroe1 6 minutes ago
Trump just told him "you're fired, get the hell out"
And for those who attack the messenger without reading contents...why? Afraid to know the truth Or or or
most likely, afraid to lose your pay check?
gawti88 gawti88 7 minutes ago
lol.yep
CEOS
dewophile dewophile 7 minutes ago
might be neck and neck if they define nearly identical as +/- 10% difference, or the culture data is a tad worse than ENTA which is in part why they didn't include it in the PR
The ability to combine drugs might give ENTA the edge in some populations who knows
It does seem like a 2 hor
ENTA
tw0122 tw0122 7 minutes ago
Headed to $1.20 likely previous resistance before selloff
HCWB
stocktowatch stocktowatch 8 minutes ago
$ALLR Allarity Therapeutics (ALLR): A Biotech Turnaround With FDA Fast-Track Potential

1. The Troubled Past: Poor Leadership and Financial Mismanagement
Allarity Therapeutics was once plagued by severe financial mismanagement, regulatory concerns, and questionable leadership. T
ALLR
Chip79 Chip79 8 minutes ago
No💹Lose-Lose! $UBQU adds $1.7M✅of long term debt in 12months✅jumping from $1,120,862 to $2,897, 117. Also increased Liabilities from $1,627,303 in 2023 to $4,698,972 in 2024.
https://www.otcmarkets.com/otcapi/company/financial-report/414119/content
UBQU
oystersnbeer oystersnbeer 8 minutes ago
“Every year, the Ontario government and its agencies spend $30 billion on procurement, alongside our $200 billion plan to build Ontario. U.S.-based businesses will now lose out on tens of billions of dollars in new revenues. They only have President Trump to blame.”

https://x.com/ford
JFBroderick JFBroderick 8 minutes ago
Clear to see the number of shareholders advocating for the company is climbing steadily.  Getting close here!
ASII
Golden Cross Golden Cross 9 minutes ago
$GRLF News-->> Announces Expansion of (COCOA-MGE-Antalya) Flavored Cigar Line.
https://www.accessnewswire.com/newsroom/en/industrial-and-manufacturing/green-leaf-innovations-grlf-celebrates-fdas-decision-to-halt-flavored-c-978444
GRLF
Golden Cross Golden Cross 9 minutes ago
$GRLF News-->> Announces Expansion of (COCOA-MGE-Antalya) Flavored Cigar Line.
https://www.accessnewswire.com/newsroom/en/industrial-and-manufacturing/green-leaf-innovations-grlf-celebrates-fdas-decision-to-halt-flavored-c-978444
GRLF
glenn1919 glenn1919 9 minutes ago
CYCN......................https://stockcharts.com/h-sc/ui?s=CYCN&p=W&b=5&g=0&id=p86431144783
CYCN
alertmeipp alertmeipp 10 minutes ago
Seems pretty much neck to neck on the challenge data. The combo optionality with both L and N might well end up to be a differentiator?
ENTA
BFarb BFarb 10 minutes ago
Yea we really need specifics of what smog armor actually does, if anything. Who works there besides Rashad? All the other execs have moved on. Monarch carbon solutions needs a facility or news of forward progress. That's their only means of future revenues through carbon limit licensing agreement an
DRNK
tw0122 tw0122 11 minutes ago
SGBX .66 merger NAHD preferred at $1 a share
NAHD SGBX
DjScottyT DjScottyT 11 minutes ago
If this company is so great, why do they need someone like TradersTrader to post ALL day long??? Wouldn’t producing something other than a stupid list and a bunch of threats be more effective for shareholders? The more that idiot posts, the less likely people are going to believe the legitimacy of t
TSOI
Bull_Dolphin Bull_Dolphin 12 minutes ago
Looks like a bloody day coming in the markets.
ccie1024 ccie1024 12 minutes ago
The Medicines and Healthcare products Regulatory Agency (MHRA) has today launched a consultation on regulatory guidance for individualised mRNA cancer immunotherapies (colloquially referred to as cancer vaccines). This is an important step in bringing these promising therapies closer to clinical pra
NWBO
BillyRaven BillyRaven 12 minutes ago
3 weeks ago Dave said he couldn't imagine it would take this long but that progress was being made, I wonder how he feels today.
BLEG
Bandicoot_Inv Bandicoot_Inv 12 minutes ago
Ocugen Announces Positive Opinion of European Medicines Agency’s Committee for Advanced Therapies for Advanced Therapy Medicinal Product Classification for Modifier Gene Therapy Candidate OCU400 for Retinitis Pigmentosa

https://www.globenewswire.com/news-release/2025/02/03/3019337/0/e
OCGN
glenn1919 glenn1919 13 minutes ago
HCWB...................MGOL............................MULN..................................https://stockcharts.com/h-sc/ui?s=MULN&p=D&yr=0&mn=3&dy=0&id=p11960084343
HCWB MGOL MULN